Keros Therapeutics Inc (KROS)

CapEx to Revenue

0.00%

Quarterly · Period ending:

KROS logo

KROS CapEx to Revenue

Latest reported0.00%
KROS Quarterly CapEx/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

KROS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
19.891%
34.8052%
0.9255%
3.963%
0.2675%
9.5003%
99.4845%
837.8378%
1,139.759%
378.3217%
6,875%
0%
0%
0%
0%
0%
0%
0.795%
0%
510%
0%
0%
0%
0%
0%
0.72%
3.28%
6.84%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.